STOCK TITAN

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Fortrea (Nasdaq: FTRE) will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. The company will host a conference call at 8:00 am ET that day to review results and hold a Q&A session.

Participants must register on the Fortrea Investor Relations website and are advised to join at least 10 minutes early to avoid delays. The call will be available via an earnings webcast, and a replay will be posted shortly after the event in the events and presentations section of the Fortrea Investor Relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.47% News Effect

On the day this news was published, FTRE gained 1.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.

A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X.

Fortrea Contacts

Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com

Sue Zaranek (Media) – 919-943-5422, media@fortrea.com

Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

When will Fortrea (FTRE) report Q3 2025 results and what is the call time?

Fortrea will release Q3 2025 results before market open on November 5, 2025, with a conference call at 8:00 am ET.

How can investors join the Fortrea (FTRE) Q3 2025 earnings call on November 5, 2025?

Investors should register online via the Fortrea Investor Relations website and join the webcast; join at least 10 minutes early to avoid delays.

Will Fortrea (FTRE) provide a replay of the November 5, 2025 earnings call?

Yes. A replay will be available shortly after the call in the events and presentations section of the Fortrea Investor Relations website.

Where is the Fortrea (FTRE) earnings webcast link for the Q3 2025 call?

The earnings webcast link will be accessible via the Fortrea Investor Relations website on the Q3 2025 results page and events section.

What topics will Fortrea (FTRE) cover during the November 5, 2025 conference call?

The company will review its Q3 2025 financial results and conduct a question-and-answer session with participants.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.59B
91.87M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM